Treace Medical Concepts
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Treace Medical Concepts generated cash of -$34,575,000, which is less than the previous year. Cash used in financing activities reached the amount of $109,383,000 last year. Net change in cash is therefore -$6,491,000.
Cash Flow
| 2019 | -7.67M | -1.21M | 19.73M |
|---|---|---|---|
| 2020 | -4.49M | -1.06M | 11.50M |
| 2021 | -17.19M | -2.70M | 107.65M |
| 2022 | -30.64M | -76.51M | 20.80M |
| 2023 | -34.57M | -81.29M | 109.38M |
TMCI Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 19.47M | 105.83M | 18.07M | 12.13M | 1.28M |
Operating activities | |||||
Net income | -49.52M | -42.81M | -20.55M | -3.66M | -4.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 5.35M | 2.13M | 685K | 1.21M | 793K |
Stock-based compensation expense | 17.35M | 8.11M | 3.40M | 919K | 815K |
| Deferred income tax benefit | 17.35M | 8.11M | 3.40M | 919K | 815K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -9.30M | -11.03M | -4.22M | -4.29M | -6.02M |
Inventories | -9.84M | -8.76M | -3.08M | -3.40M | -2.81M |
Accounts payable | 3.16M | 4.61M | 1.79M | 1.33M | -236K |
Cash generated by operating activities | -34.57M | -30.64M | -17.19M | -4.49M | -7.67M |
Investing activities | |||||
Purchases Of Investments | -169.86M | -63.40M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -11.45M | -14.83M | -2.70M | -1.06M | -1.21M |
Acquisitions Net | -20M | 61.68M | 0 | 0 | 0 |
Cash generated by investing activities | -81.29M | -76.51M | -2.70M | -1.06M | -1.21M |
Financing activities | |||||
Common Stock Issued | 107.52M | 2.18M | 109.44M | 364K | 68K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 19.60M | -1.78M | -20M | 20M |
Cash used in financing activities | 109.38M | 20.80M | 107.65M | 11.50M | 19.73M |
Net Change In Cash | -6.49M | -86.36M | 87.75M | 5.94M | 10.85M |
Cash at end of period | 12.98M | 19.47M | 105.83M | 18.07M | 12.13M |
| Data source | Data source | Data source |